BioCentury
ARTICLE | Company News

Genmab, Serono deal

May 9, 2005 7:00 AM UTC

GEN granted SEO exclusive global development and commercialization rights to HuMax-TAC. GEN will receive $2 million up front and is eligible for up to $38 million in milestones, plus royalties. GEN ha...